Home›Companies›Healthcare›Steel Therapeutics

Steel Therapeutics, Inc.

Updated Oct 27, 2026·Latest SEC filing Dec 5, 2024·Suggest an edit

About Steel Therapeutics

Steel Therapeutics is a private company based in North Liberty, Iowa, incorporated in 2020 in Delaware. It has reported $7,128,000 raised in four offerings on Form D since June 2021.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Nov 27, 2024Dec 5, 2024$2,000,000fully sold1$2.0MEquityRule 506(b)Form D ↗
Jun 1, 2023Jun 6, 2023$3,000,000fully sold1$3.0MDebt, OptionsRule 506(b)Form D ↗
Mar 30, 2022Apr 1, 2022$1,750,000of $2.0M target8$218KEquityRule 506(b)Form D ↗
May 19, 2021Jun 2, 2021$378,000of $400K target40$9,450EquityRule 504Form D ↗
Total, four offerings$7,128,000

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Steel Therapeutics's Form D filed Dec 5, 2024.

AP
SC
Sunny Chapel
Director
BC
Benjamin Clark
Executive officer and promoter
DS
MS
Matthew Stahl
Executive officer, director and promoter

Sources

  1. SECSteel Therapeutics, Inc. filing history